Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1998-11-24
|
pubmed:abstractText |
This study evaluated the anti-hypertensive efficacy, tolerability and effects on left ventricular mass of losartan, a selective angiotensin II receptor antagonist, after 22 months in patients with essential hypertension. The study included 77 hypertensive patients who were randomised at baseline to 22 months double-blind once-daily treatment with losartan 50 mg (L group n = 44 patients, mean age 54+/-9 years) or hydrochlorothiazide 25 mg (HCTZ group, n = 33 patients, mean age 56+/-7 years). Routine haematology, blood chemistry, standard electrocardiography, echocardiography and ambulatory non-invasive 24-h blood pressure (BP) monitoring were performed at baseline and after 10 and 22 months. The results showed good tolerability and a significant mean systolic and diastolic BP reduction in all groups (L group: 22 mm Hg and 11 mm Hg; HCTZ group: 11 mm Hg and 7 mm Hg, respectively for systolic and diastolic mean BP). Moreover, a remarkable reduction in left ventricular mass index was reached after 10 and 22 months only in the L group (L group: delta = -11 g/m2, P<0.02; HCTZ group: delta = -5 g/m2, P= 0.38). In conclusion, losartan was well tolerated and produced a significant reduction in BP and left ventricular mass in hypertensive patients
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0950-9240
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
505-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9759983-Adult,
pubmed-meshheading:9759983-Aged,
pubmed-meshheading:9759983-Antihypertensive Agents,
pubmed-meshheading:9759983-Double-Blind Method,
pubmed-meshheading:9759983-Female,
pubmed-meshheading:9759983-Humans,
pubmed-meshheading:9759983-Hydrochlorothiazide,
pubmed-meshheading:9759983-Hypertension,
pubmed-meshheading:9759983-Hypertrophy, Left Ventricular,
pubmed-meshheading:9759983-Losartan,
pubmed-meshheading:9759983-Male,
pubmed-meshheading:9759983-Middle Aged
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effects of losartan on hypertension and left ventricular mass: a long-term study.
|
pubmed:affiliation |
Medical Surgical Institute of Cardiology, Second University of Naples, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|